Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.
- NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_assertion description "[Utilization of mAbs directed to growth factor receptors as cancer therapeutics has been validated recently by the tumor responses obtained from clinical trials with Herceptin, the humanized anti-HER2 antibody, in patients with HER2 overexpressing metastatic breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.
- NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_assertion evidence source_evidence_literature NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.
- NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_assertion SIO_000772 11255078 NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.
- NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_assertion wasDerivedFrom befree-2016 NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.
- NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_assertion wasGeneratedBy ECO_0000203 NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP311359.RAtpAEuNNjoTOR1l9QzM1RHKo1CQ6yTrrG7poCZzCIutQ130_provenance.